Location History:
- Teaneck, NJ (US) (1981)
- Morgantown, WV (US) (2020 - 2023)
Company Filing History:
2 out of 2 
1 out of 832,891 Years Active: 1981-2023
Title: Charles L. Rosen: Innovator in Neuroprotective Solutions
Introduction: Charles L. Rosen, an accomplished inventor based in Morgantown, WV, has made significant contributions to the field of neuroprotective solutions. With two patents to his name, Rosen has demonstrated a commitment to innovation that seeks to improve healthcare outcomes, particularly for patients affected by ischemic stroke.
Latest Patents: One of his notable patents is a neuroprotective mixture designed to mitigate the harmful effects of ischemic stroke. This innovative mixture comprises Phosphocreatine (PCr), Magnesium Gluconate (MgG), and β-hydroxybutyrate (BHB) in a specific molar ratio of 2:1:2 (PCr:MgG:BHB). This formulation is intended as a preventative and prophylactic supplement, potentially extending the post-stroke treatment window for patients, thereby enhancing recovery options.
Career Highlights: Charles L. Rosen's career is marked by his work at Tricerapro Holding, LLC, where he focuses on developing advanced therapeutic solutions. His innovative efforts in neuroprotection reflect a deep understanding of clinical needs and scientific principles, positioning him as a key figure in his field.
Collaborations: Throughout his career, Rosen has collaborated with talented peers such as Joseph L. Clark and Todd J. Crocco. These partnerships not only highlight his ability to work effectively within a team but also underscore the importance of collaboration in advancing research and innovation in medical sciences.
Conclusion: With his pioneering work and patented innovations, Charles L. Rosen stands out as an influential inventor in the realm of neuroprotective strategies. His dedication to enhancing patient care, particularly for those suffering from ischemic strokes, exemplifies the impact that focused innovation can have on healthcare advancements.